title: How induced pluripotent stem cells are redefining personalized medicine.
abstract: Since the generation of the first induced pluripotent stem (iPS) cells, the stem cell field has grown at an unparalleled pace. Today, these cells have become the major tools in the advancement of personalized medicine. Here we review the experiments that lead to their discovery as well as the latest developments in iPS cell biology. By emphasizing the current applications and limitations of induced pluripotency, we discuss how iPS cells are shaping innovation in personalized therapies. In addition, we analyze the major landmarks in direct lineage reprogramming, a potentially faster alternative to the use of iPS cells in therapy. Finally, we present the current progress in disease modeling and future directions of the treatment of genetic disorders.
authors.affiliation: Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, United States. leonardoferreira@fas.harvard.edu
authors.forename: Leonardo M R
authors.initials: LM
authors.lastname: Ferreira
authors.forename: Mohammed A
authors.initials: MA
authors.lastname: Mostajo-Radji
mesh_terms: D000818:Animals; D065150:Cellular Reprogramming; D030342:Genetic Diseases, Inborn / Q000628:therapy; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000637:transplantation*; D057285:Precision Medicine